Question 1

What is Acumen Pharmaceuticals Inc (ABOS) stock price today?

Accepted Answer

Acumen Pharmaceuticals Inc (ABOS) currently trades at $2.34 per share. The stock has a market capitalization of $169.01M and a P/E ratio of —x.

Question 2

Is ABOS stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Acumen Pharmaceuticals Inc has a Smart Value Score of 25/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is —.

Question 3

What is Acumen Pharmaceuticals Inc's revenue and earnings?

Accepted Answer

Acumen Pharmaceuticals Inc has trailing twelve-month (TTM) revenue of $329000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-2.00.

Question 4

Is Acumen Pharmaceuticals Inc financially healthy?

Accepted Answer

Acumen Pharmaceuticals Inc's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of — places it in the —.

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$329000.00
Net income	$-42.86M	$-52.37M	$-102.33M	$-121.33M	$-25.14M
EPS	—	—	—	—	$-2.00
Free cash flow	$-35.31M	$-43.09M	$-86.23M	$-115.63M	$-19.10M
Profit margin	—	—	—	—	—

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ABOS	$169.01M	25	4.3	3.0	5.0	6.3	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Acumen Pharmaceuticals Inc

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare